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IgG4-related disease is a recently recognized multi-organ
disorder characterized by high levels of serum IgG4 and
dense infiltration of IgG4-positive cells into several organs.
Although the pancreas was the first organ recognized
to be affected by IgG4-related disorder in the syndrome
of autoimmune pancreatitis, we present here clinico-
pathological features of 23 patients diagnosed as having
renal parenchymal lesions. These injuries were associated
with a high level of serum IgG4 and abundant IgG4-positive
plasma cell infiltration into the renal interstitium with
fibrosis. In all patients, tubulointerstitial nephritis was the
major finding. Although 14 of the 23 patients did not have
any pancreatic lesions, their clinicopathological features were
quite uniform and similar to those shown in autoimmune
pancreatitis. These included predominance in middle-aged to
elderly men, frequent association with IgG4-related
conditions in other organs, high levels of serum IgG and
IgG4, a high frequency of hypocomplementemia, a high
serum IgE level, a patchy and diffuse lesion distribution, a
swirling fibrosis in the renal pathology, and a good response
to corticosteroids. Thus, we suggest that renal parenchymal
lesions actually develop in association with IgG4-related
disease, for which we propose the term ‘IgG4-related
tubulointerstitial nephritis.’
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IgG4-related disease represents a recently recognized group
of multi-organ diseases characterized by a high level of
serum IgG4 and dense infiltration of IgG4-positive cells into
multiple organs.1–3 The condition was first described in
relation to the pancreas (that is, autoimmune pancreatitis
(AIP)),4 and has since been expanded to various organ
systems. At present, many other inflammatory conditions
affecting multiple organs are considered to fall within the
category of IgG4-related disease,1–3 including sclerosing
cholangitis,5 sialadenitis,2,6 retroperitoneal fibrosis,7 inter-
stitial pneumonitis,8 inflammatory pseudotumor,1–3 and
periaortitis.9 Although much attention is now being focused
on these conditions, and the number of case reports of
IgG4-related disease has been increasing, there are still
few clinicopathological data on the involvement of organs
other than the pancreas. The aim of this study was to
elucidate the clinicopathological characteristics of renal
parenchymal lesions associated with IgG4-related disease.
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RESULTS
Patient profiles
Patients were all Japanese (20 men and 3 women) with an
average age of 65.2±10.1 (40–83) years at the time of diagnosis
of renal disease. Although seven patients fulfilled the criteria for
Sjo¨gren’s syndrome, as revised by the Japanese Ministry of
Welfare in 1999, none of them met the criteria for systemic
lupus erythematosus, anti-neutrophil cytoplasmic antibody
(ANCA)-related vasculitis, rheumatoid arthritis, or sarcoidosis.
None of the organ specimens showed any evidence of malignant
lymphoma by the DNA PCR method or immunohisto-
chemistry. At the time of diagnosis of renal involvement, one
patient had been treated with low-dose corticosteroid
(prednisolone 2.5mg daily) because of AIP (patient 5 in
Table 1). Three patients had been treated with the corticosteroid
because of AIP (patients 19 and 22 in Table 1) or idiopathic
thrombocytic purpura (patient 8 in Table 1), but the treatment
was discontinued when they developed renal involvement. The
other 19 patients had not received corticosteroids or immuno-
suppressants before the appearance of renal lesions.
Clinical features
Of the 23 patients, 22 (95.7%) had some accompanying
extrarenal lesions: sialadenitis in 19 (82.6%), lymphadeno-
pathy in 10 (43.5%), AIP in 9 (39.1%), dacryoadenitis in
7 (30.4%), lung lesions (interstitial pneumonitis and nodular
lesions) in 6 (26.0%), and others in 3 (pseudotumor of
the liver, prostatitis, and idiopathic thrombotic purpura)
(Table 1). Among the extrarenal lesions, 15 (represented in
bold in Table 1) had been recognized before diagnosis of the
renal lesions, and 10 of these 15 lesions in patients 3, 5, 8, 19,
and 22 had improved with steroid therapy, or spontaneously,
at the time of diagnosis of the renal lesions. The other 39
lesions were diagnosed at the same time as the renal lesions.
Clinical symptoms were mostly associated with extrarenal
lesions, such as gland swelling and lymphadenopathy. Fever,
arthralgia, skin eruption, and edema were observed in 3, 5, 1,
and 2 patients, respectively. In 21 of the 23 patients, the renal
lesions were observed by physicians because of urinary
abnormalities, renal dysfunction, and/or abnormalities re-
vealed by radiological examinations, including computed
tomography (CT) and gallium citrate scintigraphy, during
follow-up or further examinations of the IgG4-related
extrarenal lesions. In patients 13 and 14, renal lesions were
observed because of renal dysfunction in the absence of
extrarenal lesions. The results of renal histological and
laboratory findings alerted the attending physicians to
IgG4-related disease, who then carried out measurements
of serum IgG4 levels and IgG4 immunostaining. (Additional
gallium citrate scintigraphy showed gallium-67 accumulation
of both the salivary glands in patient 13.)
Laboratory findings at the time of diagnosis of the renal
lesions
Urinary protein excretion was o0.3 g/day in 19 of the 23
patients (Table 1). Urinary protein excretion 41.0 g/day was
shown in two patients with membranous nephropathy
(patients 14 and 22). Hematuria (urinary red blood cells
43 per h.p.f. (high-power field)) was shown in eight
patients. Although mostly mild, hematuria with urinary red
blood cells 420 per h.p.f. was evident in three patients with
glomerular lesions (patients 14, 22, and 23). Hematological
examinations revealed anemia (hemoglobin o10.0 g/dl) in
only one patient (hemoglobin 9.0 g/dl in patient 20).
Although white blood cell counts were within the normal
range in most patients (mild leukocytosis was observed in
2 patients), eosinophila (eosinophils 45%) was observed in
11 patients (47.8%). Platelet counts were within the normal
range in all patients. Renal function varied from normal to
renal failure (serum creatinine 0.67–6.87mg/dl). Elevated
creatinine levels (serum creatinine 41.2mg/dl) were shown
in 13 of the 23 patients. Abnormal liver function at the
time of diagnosis of the renal lesions was observed in three
patients; AST (aspartate transaminase) 53 IU/l (range:
13–33), ALT (alanine transaminase) 101 IU/l (range: 10–47),
ALP (alkaline phosphatase) 914 IU/l (range: 115–359) in
patient 4, AST 16 IU/l, ALT 20 IU/l, ALP 573 IU/l in patient 5,
and AST 55 IU/l, ALT 115 IU/l, ALP 1690 IU/l in patient 22.
Pancreatic swelling due to AIP had improved by this time in
patients 5 and 22, and no patient showed CT abnormalities
in the liver or pancreatobiliary system.
All patients showed elevated levels of serum IgG
(2721–8841mg/dl, mean 4836±1499mg/dl, normal range
870–1700). Although serum IgA and IgM levels were within
the normal ranges in all patients, elevation of the serum
IgE level (272–4442 IU/ml, normal range o250 IU/ml) was
observed in 10 of 14 evaluated patients (71.4%). Serum IgG4
levels before steroid therapy ranged from 587 to 4630mg/dl
(mean 1520±909, normal range o105mg/dl). In 16 of the
23 patients (69.6%), the serum CH50 level was found to be
decreased, together with a reduction in the serum level of C3,
C4, or both. In two patients (nos 20 and 21), only the C3
level was decreased. The rheumatoid factor was positive in
7 of 18 evaluated patients (38.9%). Although anti-nuclear
antibodies were positive in 69.6%, anti-SS-A, anti-SS-B,
anti-Sm, and anti-RNP antibodies were all negative, and the
levels of anti-DNA antibodies were not increased in any of
the patients. The level of CRP waso1.5mg/dl in 22 of the 23
patients, and 8.7mg/dl in 1 patient (patient 7). Cryoglobulin,
M-protein, myeloperoxidase-ANCA, and proteinase-3-
ANCA were not observed in any of the patients.
Imaging studies
CT revealed abnormal renal parenchymal lesions in 16 of the
23 patients (69.6%) (Table 1). Among them, diffuse swelling
of the bilateral kidneys was evident in seven patients. Patchily
distributed hypoattenuated lesions in the renal cortex,
being single or multiple, round or wedge shaped, were found
in 10 patients (Figure 1). Renal pelvic tumor and calicectasis
were observed in addition to the renal parenchymal lesions
in patients 2 and 4, respectively. In patient 1, thickening
of the renal pelvic wall was observed, although no renal
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parenchymal lesion was evident. Gallium citrate scintigraphy
was performed before therapy in 17 patients (nos 2–9, 11–18,
and 21), and all but 2 (nos 2 and 14) showed gallium-67
accumulation in both the kidneys. Gallium citrate scinti-
graphy performed during therapy showed no gallium-67
accumulation in the kidneys (patients 10 and 21).
Renal pathology
Tubulointerstitial nephritis was a dominant feature in all
patients (Table 1). Light microscopy demonstrated dense cell
infiltration with fibrosis and tubular atrophy. The infiltrate
was predominantly composed of plasma cells and lympho-
cytes, and also eosinophils in some patients. Distribution of
the lymphoplasmacytic infiltration was not only diffuse but
also patchy, sometimes with a clear margin (Figure 2a and b).
Tubule atrophy or diminishment developed according to
the severity of cell infiltration and fibrosis. In the fibrotic
interstitium, collagen fibers exhibited a swirling pattern
or an arabesque outline in periodic acid-methenamine
silver-stained preparations, and inflammatory cells infil-
trated the collagen fibers, producing a characteristic pattern
(Figure 2c and d). On light microscopy, the glomeruli were
unremarkable in 18 patients, except for evidence of focal
global sclerosis. One patient (no. 14) showed membranous
nephropathy. Mild mesangioproliferative glomerulonephritis
was evident in three patients (nos 6, 11, and 16), and focal
segmental endocapillary hypercellularity was observed in
one (no. 23). Direct immunofluorescence was evaluated in
14 patients (nos 1, 2, 5, 6, 9, 10, 11, 13, 14, 16, 18, 19, 21,
and 22). In three patients (nos 1, 18, and 21), deposition of
immunoglobulins and complement components was not
confirmed in the glomeruli or the interstitium. In the patient
with membranous nephropathy (no. 14), diffuse and global
IgG and C3 deposits along the glomerular capillary walls, and
focal deposits of IgG and C3 along the tubular basement
membranes were observed. In patient 22, no deposition was
observed in the glomeruli, and parts of the tubular basement
membranes were positive for C3 deposition. Although the
glomeruli on light microscopy were also unremarkable in
the patient, electron microscopy revealed segmental sub-
epithelial deposits on the glomerular basement membranes,
and therefore, we diagnosed the patient as having tubuloin-
terstitial nephritis with membranous nephropathy.10 In three
patients with mild mesangioproliferative glomerulonephritis
(nos 6, 11, and 16), no apparent deposit was evident on the
tubular basement membranes. In two of these patients (nos
6 and 16), mild IgG and IgA deposits (IgA was not dominant)
were observed in the mesangial areas. In the other patient
(no. 11), dominant IgA deposition was observed in the
mesangial area, and we diagnosed the patient as having
tubulointerstitial nephritis with IgA nephropathy. In four of
Figure 1 |Contrast-enhanced renal CT findings in patients
with IgG4-related nephropathy. (a) Multiple wedge-shaped
low-attenuation lesions in both renal cortices are evident (arrows,
patient 3); (b) A tumor-like less-enhanced mass (arrow) is evident
in the left kidney (patient 8). CT, computed tomography.
Figure 2 | Light microscopy findings in the renal tissues.
(a) Diffuse marked renal interstitial inflammation consisting of
lymphocytes and plasma cells with fibrosis is demonstrated, and
most tubules are diminished (patient 8, HE; original magnification
 200); (b) Patchy distribution of dense lymphoplasmacytic
infiltrates with irregular fibrosis, showing a clear margin (patient
16, PAM-Masson; original magnification  80); (c, d) Collagen
fibers exhibit a swirling pattern or an arabesque outline in a PAM-
stained preparation, and the inflammatory cells show infiltration
into the collagen fibers (panel c; patient 13, PAM-Masson; original
magnification  200, panel d; patient 21, PAM-Masson; original
magnification  250). HE, hematoxylin and eosin; PAM, periodic
acid-methenamine.
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the other six patients (nos 5, 9, 13, and 19), segmental
staining for IgG or C3 was shown in the glomeruli, with no
deposits on the tubular basement membrane; faint or mild
segmental mesangial staining for IgG in patients 5, 9, and 19,
and mild segmental staining for C3 along the glomerular
capillary wall in patient 13. In the other two patients (nos
2 and 10), nonspecific faint segmental staining for C3 was
evident on the tubule basement membranes, without any
deposits in the glomeruli.
Immunostaining for IgG4 revealed infiltration of numer-
ous IgG4-positive plasma cells (IgG4-positive plasma
cells/IgG-positive plasma cells 440%; IgG4-positive plasma
cells 410 per h.p.f.) into the renal interstitium (Figure 3a).
In the patient with membranous nephropathy (no. 14),
IgG4 immunostaining also showed diffuse reactivity in the
glomerular capillary walls, and focal staining of the tubule
basement membrane, in addition to the infiltrating plasma
cells (Figure 3b).
Treatment and course
The treatment regimen was decided according to the opinion
of each attending physician (Table 1). Of the 23 patients, 21
were treated with prednisolone (initial dose 10–60mg/day)
for renal lesions. Intravenous methylprednisone pulse
therapy (500–1000mg for 3 days) was also conducted in
three patients. One patient (no. 3) was followed up without
therapy because both AIP and renal lesions improved
spontaneously. Among patients treated with corticosteroid,
the clinical data after 4 weeks were evaluable in 19. In 18 of
those patients, abnormalities of renal function, complement
level, and imaging features were all improved by therapy.
Extrarenal lesions were also improved. In one patient with
renal failure (no. 22), renal function did not recover, and
maintenance hemodialysis became necessary.
DISCUSSION
Lesions of the kidney associated with IgG4-related disease
include those affecting the renal parenchyma, and lesions of
other areas.7,11 Renal parenchymal lesions associated with
IgG4-related disease were first described in 2004 as case
reports of tubulointerstitial nephritis associated with AIP.12,13
Thereafter, the number of case reports of tubulointerstitial
nephritis associated with IgG4-related disease has been
increasing,14–18 although most of such cases have been
accompanied by AIP and their number is still limited.
The clinicopathological features of IgG4-related disease
have been described most extensively for cases with
pancreatic involvement (that is, AIP).19–22 It predominantly
affects middle-aged to elderly men. The clinical symptoms
are mild and the condition usually comes to clinical atten-
tion because of imaging abnormalities of the pancreas
or obstructive jaundice. In most patients, extrapancreatic
lesions, such as sclerosing cholangitis, sclerosing sialadenitis,
lymphadenopathy, and retroperitoneal fibrosis occur during
the clinical course, sometimes simultaneously and often
metachronously.23 Laboratory examinations reveal character-
istically increased levels of serum IgG and IgG4 (increased
serum IgG4 is observed in 68–90% of Japanese patients
with AIP),22 and a recent study has shown that the serum IgE
level is also frequently elevated.24 Antinuclear antibodies and
rheumatoid factor are often positive, but anti-SSA and anti-
SSB antibodies are negative,21 and hypocomplementemia is
observed in 17–36% of the patients.25 CT scan or magnetic
resonance imaging shows diffuse pancreatic enlargement or
focal masses. Corticosteroid therapy is usually quite effective
for normalizing pancreatic lesions, and also the clinical and
laboratory parameters. Histopathologically, dense lympho-
plasmacytic infiltration, swirling or storiform fibrosis, and
abundant IgG4-positive plasma cell infiltration revealed
by IgG4 immunostaining are characteristic, and several
studies have shown that IgG4-related disease shows similar
pathological features, regardless of the specific type of organ
involved.8,26 In this study, we diagnosed 23 patients as having
renal parenchymal lesions associated with IgG4-related
disease on the basis of the renal pathological features
described above, in addition to high levels of serum IgG4.
As an elevated serum IgG4 level is characteristic of IgG4-
related disease, but not diagnostic (sensitivity 75%, specificity
93% in AIP),20 histopathological examination including IgG4
Figure 3 | Immunostaining of IgG4 in renal tissues.
(a) Numerous IgG4-positive plasma cells are evident in the renal
interstitium (patient 13, original magnification  250); (b) In the
patient with membranous nephropathy (patient 14), diffuse
staining of glomerular capillary walls is also shown in addition to
the IgG4-positive infiltrating plasma cells in the renal interstitium
(original magnification  400).
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immunostaining is useful for diagnosis of this disease in
addition to an elevated serum IgG4 level. Although 14 of the
23 patients did not have any pancreatic lesions, the clinical
features were quite uniform and similar to those shown in
AIP. Our results suggested that renal parenchymal lesions
actually developed in association with IgG4-related disease,
but not in association with AIP.
Tubulointerstitial nephritis is caused by various factors,
including infections, drug reactions, urinary tract obstruc-
tion, autoimmune conditions, plasma cell dyscrasias, and
metabolic disorders. Many patients in the present series
showed hypergammaglobulinemia, hypocomplementemia,
and positivity for anti-nuclear antibodies, being reminiscent
of systemic lupus erythematosus, but none of them met the
criteria for it. Although seven of the patients fulfilled the
ordinary criteria for Sjo¨gren’s syndrome, typical Sjo¨gren’s
syndrome does not show elevation of the serum IgG4 level
and abundant IgG4-positive plasma cell infiltration.3 Recent
studies have shown that there are considerable differences
between IgG4-related disease and Sjo¨gren’s syndrome,
although distributions of the involved organs are similar,2,3
and therefore it is important to recognize IgG4-related
disease and to distinguish it from Sjo¨gren’s syndrome.27 The
clinical symptoms, laboratory findings such as hypo-
complementemia, a low CRP level and negativity for ANCA,
and also radiological findings, differed from those of
drug-induced tubulointerstitial nephritis, infection, and
ANCA-related vasculitis. The clinicopathological features of
tubulointerstitial nephritis associated with IgG4-related
disease are thus unique and distinct from those of other
renal diseases.
Despite the characteristic clinicopathological features,
the pathogenesis of IgG4-related disease remains poorly
understood, although autoimmune or allergic mechanisms
have been discussed.5,19,20 Cornell et al.28 demonstrated IgG4
immune-complex deposition in the renal tubule basement
membranes of patients with tubulointerstitial nephritis
associated with AIP, suggesting an immune-complex
mechanism. In the present series, an apparent deposition of
immune complex on the tubular basement membranes was
evident in only one of the patients with membranous
nephropathy by direct immunofluorescence. On the other
hand, the relationship between glomerular lesions and IgG4-
related disease is also poorly understood. Although the major
pathological feature of this disease is tubulointerstitial
nephritis, the glomeruli were also affected in a small number
of cases in this study, and this has also been described
previously,12,15,29,30 membranous nephropathy being the
most frequent feature among them. The significance of
IgG4 has been documented in idiopathic membranous
nephropathy, in which the predominance of Th2 cytokines
is a common feature,31,32 and also in IgG4-related disease,5
suggesting a possible relationship between them. In view of
the possible association of renal lesions with IgG4-related
disease, glomerular lesions should be examined closely
in addition to interstitial lesions. Further large-scale and
detailed clinicopathological studies including electron micro-
scopy examinations will be necessary to elucidate the
pathogenesis of IgG4-related renal lesions.
As the concept of IgG4-related disease was proposed
relatively recently, it remains largely unrecognized by most
clinicians. However, accurate diagnosis of IgG4-related
disease is very important because steroid therapy is usually
quite effective.19–22 In this study, the renal lesions had
improved with corticosteroid therapy in most patients at the
time of the 4-week follow-up. However, renal function did
not recover in one patient (no. 22) with renal failure.10
Although in this study we were unable to characterize the
clinicopathological differences between patients with better
or worse renal function, because it was a retrospective
analysis and only one patient showed worsened renal
function after treatment, it is important to be aware that
renal failure may also occur in IgG4-related disease if the
diagnosis is delayed. Nephrologists should be aware of the
condition in patients with tubulointerstitial nephritis, and
measure the serum IgG4 level, especially when there is
associated sialadenitis, lymphadenopathy, hypergammaglo-
bulinemia, eosinophilia, hypocomplementemia,41 and a
patchy lesion distribution. In addition, clinicians should be
vigilant for the development of renal lesions at any time when
following the course of involvement of other organs in
patients with any IgG4-related disease, such as AIP. In five of
the present patients, renal lesions developed during remission
of the condition in other organs.
In conclusion, renal parenchymal lesions associated with
IgG4-related disease appear to have characteristic clinico-
pathological features in comparison with those of other renal
diseases, and therefore we propose the term ‘IgG4-related
tubulointerstitial nephritis’ for this condition.
MATERIALS AND METHODS
Patients and methods
A total of 153 patients with suspected IgG4-related disease were
collected retrospectively from 22 collaborating institutions in Japan
between September 2004 and August 2009, among whom 30 were
diagnosed as having renal parenchymal abnormalities by their
physicians. Among these 30 patients, we diagnosed 23 as having
renal parenchymal lesions associated with IgG4-related disease. (In
Table 1, patients nos 3, 4, 5, 6, 8, 9, 13–16, 18 and 22 have been
previously reported in references 10, 14, and 33–40.) The diagnosis
was based on a high serum IgG4 level (4135mg/dl) and numerous
infiltration of IgG4-positive plasma cells into the renal interstitium
(IgG4-positive plasma cells/IgG-positive plasma cells 440%; IgG4-
positive plasma cells 410 per h.p.f.) with fibrosis. Although the
serum IgG4 level was not measured in one patient, we also
diagnosed this patient as having renal parenchymal involvement
associated with IgG4-related disease because of the presence of
tubulointerstitial nephritis with infiltration of numerous IgG4-
positive plasma cells into the renal interstitium with typical AIP and
Mikulicz’s disease. In the other 7 of 30 patients, renal parenchymal
abnormalities were diagnosed on the basis of radiographic
abnormalities. Five of these patients were diagnosed as having
IgG4-related sialadenitis and dacryoadenitis and showed multiple
hypoattenuating lesions in the renal cortex by contrast-enhanced
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CT, with normal urinalysis values and normal renal function. One
other patient (under hemodialysis) was diagnosed as having IgG4-
related sclerosing cholangitis and end-stage renal disease, with
evidence of a mass lesion in the right kidney by nonenhanced CT.
Renal biopsy was not performed in these six patients. Another
patient showed a right renal mass lesion and a high serum IgG4
level, with normal urinalysis values and mild renal dysfunction. As
the tissue obtained by CT-guided renal biopsy of the mass lesion did
not include any renal parenchyma, even though marked lympho-
plasmacytic infiltration was observed in the adipose tissues, we
excluded this patient.
In the 23 patients diagnosed as having renal parenchymal
lesions associated with IgG4-related disease, we retrospectively
examined the clinical features, data from laboratory and imaging
studies, and the clinical response to treatment. Whole-body
CT imaging was evaluated in all patients (contrast-enhanced
CT in 21 patients). Gallium citrate scintigraphy was performed in
19 of the 23 patients, before therapy in 17 and during therapy
in 2. The diagnosis of AIP was made in accordance with the 2006
Japan Pancreas Society revised criteria.42 Sialadenitis and dacryo-
adenitis were diagnosed on the basis of physical findings, and the
results of imaging studies (CT and gallium citrate scintigraphy) and/
or biopsy.
The study was approved by the review board of the Nagaoka Red
Cross Hospital and the boards of the various collaborating
institutions. All data and samples from patients were collected with
their informed consent, and the research was conducted in
compliance with the principles of the Declaration of Helsinki.
Renal pathology
Renal pathological examination was conducted at the request of the
attending physicians because of urinary abnormalities, renal
dysfunction, and/or radiological abnormalities. Renal tissues were
obtained by nondirected medical needle biopsy in 21 patients, by
open biopsy of the mass lesion in 1 patient (no. 8), and by autopsy
in 1 patient (no. 3), who died of lung cancer. All renal tissue
specimens were examined by light microscopy. Direct immuno-
fluorescence studies were conducted in 17 patients, and we evaluated
14 specimens because 3 were considered inadequate. For routine
light microscopy studies, renal biopsy specimens were fixed in
formalin or alcohol-Bouin, embedded in paraffin, and stained with
hematoxylin and eosin, periodic acid-Schiff, periodic acid-methe-
namine silver, and Masson’s trichrome. For immunostaining,
formalin-fixed, paraffin-embedded biopsy specimens were cut into
3-mm thick sections, and the sections were immunostained using
anti-IgG antibody (Dako, Glostrup, Denmark) and mouse mono-
clonal antibody against human IgG4 (Zymed Laboratory, San
Francisco, CA, USA, or The Binding Site, Birmingham, UK). For
direct immunofluorescence studies, tissues were snap frozen, and
sections were treated with fluorescein isothiocyanate-conjugated
rabbit anti-human IgG, IgA, IgM, C1q, C3c, or fibrinogen (Dako,
Carpinteria, CA, USA).
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